ONOGATE
LIVE

Serial Number

88833703

Owner

PT. Natura Nuswantara Nirmala

Attorney

Judd Patton

Filing Date

Mar 13, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ONOGATE Trademark

Serial Number: 88833703 • Registration: 6209391

ONOGATE is a trademark filed by PT. Natura Nuswantara Nirmala on March 13, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

PT. Natura Nuswantara Nirmala (2 trademarks)

Pondok Pucung Pondock Aren
Tangerang Selatan 15429 , ID

Entity Type: 99

Trademark Details

Filing Date

March 13, 2020

Registration Date

December 1, 2020

Published for Opposition

September 15, 2020

Goods & Services

Amino acid preparations for medical purposes; Amino acids for medical purposes; Dietary supplements; Dietary supplements also containing herbal extracts; Dietary supplements also containing amino acids; Dietary supplements also containing collagen; Dietary supplements also containing iron; Dietary supplements also containing calcium; Dietary supplements also containing magnesium; Dietary supplements also containing minerals and trace elements; Dietary supplements also containing vitamins; Dietary supplements for human consumption; Dietary supplements with a cosmetic effect; Dietary and nutritional supplements containing amino acids; Dietary and nutritional supplements containing collagen; Herbal extracts for medical purposes; Herbal supplements; Herbal supplements for sleeping problems; Herbal tinctures for medical purposes; Herbs for medicinal purposes; Nutritional supplements; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of spondyloarthropathy; Pharmaceutical preparations, namely, analgesic properties; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of joint disease; Vitamin and mineral preparations for medical use; Vitamin and mineral supplements; Albumin dietary supplements; Allergy capsules; Anti-inflammatories; Anti-inflammatory preparations; Dietary and nutritional supplements; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Ethers for pharmaceutical purposes; Fish meal for pharmaceutical purposes; Herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; Liquid herbal supplements; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal herbs in dried or preserved form; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Mineral nutritional supplements; Natural dietary supplements; Natural herbal supplements; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treatment of bone disease; Nutraceuticals for use as a dietary supplement for treatment of joint health; Nutraceuticals for use as a dietary supplement for treatment of rheumatoid arthritis; Nutraceuticals for use as a dietary supplement for treatment of spondyloarthropathy; Plant extracts for pharmaceutical purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Therapeutic pharmaceutical for the treatment of rheumatoid arthritis; Therapeutic pharmaceutical for the treatment of skeletal diseases and disorders; Therapeutic pharmaceutical for the treatment of spondyloarthropathy

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 1, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 1, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 15, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 15, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 7, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 7, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 7, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 7, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 7, 2020 CNEA
EXAMINER'S AMENDMENT ENTERED
Jul 24, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 24, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 24, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 24, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2020 CRFA
ASSIGNED TO LIE
Jul 2, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 22, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 12, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 12, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 12, 2020 CNRT
REMOVED FROM TEAS PLUS
Jun 12, 2020 RFTP
ASSIGNED TO EXAMINER
Jun 5, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 20, 2020 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 19, 2020 NWOS
NEW APPLICATION ENTERED
Mar 17, 2020 NWAP